175 related articles for article (PubMed ID: 30560239)
1. Interstitial Pneumonia in Psoriasis.
Kawamoto H; Hara H; Minagawa S; Numata T; Araya J; Kaneko Y; Umezawa Y; Asahina A; Nakagawa H; Kuwano K
Mayo Clin Proc Innov Qual Outcomes; 2018 Dec; 2(4):370-377. PubMed ID: 30560239
[TBL] [Abstract][Full Text] [Related]
2. Effect of anti-interleukin-17 biologics on Krebs von den Lungen-6 level in patients with psoriasis.
Hara H; Miyagawa H; Araya J; Minagawa S; Numata T; Umezawa Y; Asahina A; Nakagawa H; Kuwano K
J Dermatol; 2021 Jun; 48(6):886-893. PubMed ID: 33860559
[TBL] [Abstract][Full Text] [Related]
3. Characteristics of anti-IL-17/23 biologics-induced interstitial pneumonia in patients with psoriasis.
Miyagawa H; Hara H; Araya J; Minagawa S; Numata T; Umezawa Y; Asahina A; Nakagawa H; Kuwano K
PLoS One; 2021; 16(1):e0245284. PubMed ID: 33411857
[TBL] [Abstract][Full Text] [Related]
4. Serum Krebs von den Lungen-6 levels in psoriatic patients under treatment with biologics.
Iwata H; Haga N; Sugai T; Fujita Y
J Dermatol; 2021 Mar; 48(3):376-379. PubMed ID: 33146900
[TBL] [Abstract][Full Text] [Related]
5. Change in Serum KL-6 Level during Biologic Treatment for Psoriasis.
Hoashi T; Miyazaki S; Ozaki S; Ichiyama S; Ito M; Kanda N; Saeki H
J Nippon Med Sch; 2023; 90(2):194-201. PubMed ID: 37258257
[TBL] [Abstract][Full Text] [Related]
6. Potential of Krebs von den Lungen-6 as a predictor of relapse in interstitial pneumonia with anti-aminoacyl tRNA synthetase antibodies-positive dermatomyositis.
Isoda K; Kotani T; Takeuchi T; Konma J; Ishida T; Hata K; Otani K; Fujiwara H; Shoda T; Makino S; Arawaka S
Clin Respir J; 2018 Jul; 12(7):2235-2241. PubMed ID: 29633527
[TBL] [Abstract][Full Text] [Related]
7. Krebs von den Lungen-6 associated with chest high-resolution CT score in evaluation severity of patients with interstitial lung disease.
Qin H; Xu XP; Zou J; Zhao XJ; Wu HW; Zha QF; Chen S; Kang Y; Jiang HD
Pulmonology; 2019; 25(3):143-148. PubMed ID: 30007895
[TBL] [Abstract][Full Text] [Related]
8. Clinical characteristics and response to biological therapies for inverse psoriasis: a real-life comparison between the therapeutic effects of anti-IL-23 and anti-IL-17 agents.
Mastorino L; Dapavo P; Macagno N; Ortoncelli M; Verrone A; Stroppiana E; Cariti C; Susca S; Siliquini N; di Corteranzo IG; Quaglino P; Ribero S
Int J Dermatol; 2024 May; ():. PubMed ID: 38751026
[TBL] [Abstract][Full Text] [Related]
9. Successful control of juvenile dermatomyositis-associated macrophage activation syndrome and interstitial pneumonia: distinct kinetics of interleukin-6 and -18 levels.
Wakiguchi H; Hasegawa S; Hirano R; Kaneyasu H; Wakabayashi-Takahara M; Ohga S
Pediatr Rheumatol Online J; 2015 Nov; 13():49. PubMed ID: 26581448
[TBL] [Abstract][Full Text] [Related]
10. A case of vildagliptin-induced interstitial pneumonia.
Kuse N; Abe S; Kuribayashi H; Inomata M; Saito H; Fukuda Y; Gemma A
Respir Med Case Rep; 2016; 18():10-3. PubMed ID: 27144110
[TBL] [Abstract][Full Text] [Related]
11. Twelve-week secukinumab treatment is consistently efficacious for moderate-to-severe psoriasis regardless of prior biologic and non-biologic systemic treatment: Post hoc analysis of six randomised trials.
Hampton P; Halliday A; Aassi M; Subramanian S; Jain M; Griffiths CEM
J Eur Acad Dermatol Venereol; 2021 Apr; 35(4):928-937. PubMed ID: 33030755
[TBL] [Abstract][Full Text] [Related]
12. Secukinumab decreases serum Krebs von den Lungen 6 (KL-6) level in patients with psoriasis with elevated serum KL-6 level.
Chijiwa C; Takeoka S; Kamata M; Uchida H; Fukaya S; Hayashi K; Fukuyasu A; Tanaka T; Ishikawa T; Ohnishi T; Tada Y
Br J Dermatol; 2018 Dec; 179(6):1396-1397. PubMed ID: 29985537
[No Abstract] [Full Text] [Related]
13. Guselkumab versus secukinumab for the treatment of moderate-to-severe psoriasis (ECLIPSE): results from a phase 3, randomised controlled trial.
Reich K; Armstrong AW; Langley RG; Flavin S; Randazzo B; Li S; Hsu MC; Branigan P; Blauvelt A
Lancet; 2019 Sep; 394(10201):831-839. PubMed ID: 31402114
[TBL] [Abstract][Full Text] [Related]
14. Comparison of ixekizumab with ustekinumab in moderate-to-severe psoriasis: 24-week results from IXORA-S, a phase III study.
Reich K; Pinter A; Lacour JP; Ferrandiz C; Micali G; French LE; Lomaga M; Dutronc Y; Henneges C; Wilhelm S; Hartz S; Paul C;
Br J Dermatol; 2017 Oct; 177(4):1014-1023. PubMed ID: 28542874
[TBL] [Abstract][Full Text] [Related]
15. Elevated serum Krebs von den Lungen-6 in systemic sclerosis: a marker of lung fibrosis and severity of the disease.
Benyamine A; Heim X; Resseguier N; Bertin D; Gomez C; Ebbo M; Harlé JR; Kaplanski G; Rossi P; Bardin N; Granel B
Rheumatol Int; 2018 May; 38(5):813-819. PubMed ID: 29455320
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of combination therapy with prednisolone and oral tacrolimus for progressive interstitial pneumonia with systemic sclerosis: A retrospective study.
Konma J; Kotani T; Shoda T; Suzuka T; Fujiki Y; Nagai K; Hata K; Yoshida S; Takeuchi T; Makino S; Arawaka S
Mod Rheumatol; 2018 Nov; 28(6):1009-1015. PubMed ID: 29442534
[TBL] [Abstract][Full Text] [Related]
17. Early detection of colon cancer by increased serum level of Krebs von den Lungen-6 in a patient with dermatomyositis-associated interstitial pneumonia.
Fukuhara N; Tanino Y; Sato S; Fukuhara A; Uematsu M; Nikaido T; Misa K; Sato Y; Saito J; Wang X; Munakata M
Sarcoidosis Vasc Diffuse Lung Dis; 2015 Sep; 32(3):265-70. PubMed ID: 26422573
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the Diagnostic Efficacies of Serological Markers KL-6, SP-A, SP-D, CCL2, and CXCL13 in Idiopathic Interstitial Pneumonia.
Xue M; Guo Z; Cai C; Sun B; Wang H
Respiration; 2019; 98(6):534-545. PubMed ID: 31665737
[TBL] [Abstract][Full Text] [Related]
19. Spontaneous improvement of interstitial pneumonia with autoimmune features: A case report.
Ohkubo H; Nakano A; Fujita K; Ozawa Y; Murase T; Niimi A
Respirol Case Rep; 2021 Nov; 9(11):e0867. PubMed ID: 34707878
[TBL] [Abstract][Full Text] [Related]
20. Nonspecific interstitial pneumonia with fibrosis: high-resolution CT and pathologic findings.
Kim TS; Lee KS; Chung MP; Han J; Park JS; Hwang JH; Kwon OJ; Rhee CH
AJR Am J Roentgenol; 1998 Dec; 171(6):1645-50. PubMed ID: 9843306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
